ArticleAfrican journal of thoracic and critical care medicine2026
Severely reduced antioxidant and impaired mitochondrial biomarkers could be linked to post-tuberculosis lung disease in a cohort from South Africa.
Article in African journal of thoracic and critical care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Catalysing future research on the under-recognised burden of post-tuberculosis pulmonary hypertension.African journal of thoracic and critical care medicine · 2026Article
- Molecular signaling in coinfection: howFrontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-tuberculosis lung disease (PTLD) refers to unresolved lung damage and impaired lung function after successful treatment of tuberculosis (TB). Its pathogenesis is not fully understood, and we hypothesised that antioxidant-oxidant and mitochondrial factors may be instrumental. Objectives: To investigate the involvement of mitochondrial and antioxidant-oxidant biomarkers in TB patients who had had more than one previous TB episode and were in the post-TB stage of disease. Methods: Enzyme-linked immunosorbent assays were conducted on patient serum. Results: Lipid peroxidation (measured with the thiobarbituric acid reactive substances assay) was within the normal range. In contrast, the mitochondrial regulator metallothionein-1 was 240 times lower, catalase activity 7.5 times lower, and superoxide dismutase activity 273 times lower than the normal ranges for these markers. Hypoxia-inducible factor-1-alpha (HIF-1α) was below the limit of detection. The mitochondrial markers were similar across the stratified groups after stratifying the patients based on the number of previous TB episodes. Age positively correlated with the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/e'), a marker of left ventricular filling pressure, and it marginally correlated with pulmonary artery systolic pressure, while there were no other notable correlations. Conclusion: Our data demonstrate that antioxidant enzyme activities are extremely low in post-TB patients. A key mitochondrial protein, HIF-1α, showed no role in this context, which could suggest that these patients are not hypoxic. A novel contributor to PTLD could therefore be a limitation of antioxidant capacity and mitochondrial pathways, which is not linked to the number of previous TB episodes but may highlight the need to consider antioxidant therapy during the post-TB stage. Further research is warranted. Study synopsis:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.